Register for email alerts and news feeds:
This journal | BMJ Group
rss
Thorax 2003;58:283; doi:10.1136/thorax.58.4.283-a
Copyright © 2003 BMJ Publishing Group Ltd & British Thoracic Society.
Thorax 2003;58:283
© 2003 BMJ Publishing Group & British Thoracic Society

Airwaves

Wisia Wedzicha, Editor in Chief

The first 150 words of the full text of this article appear below.

EXHALED MARKERS AT COPD EXACERBATIONS

Exacerbations of COPD are an important cause of morbidity in COPD and affect disease progression. There is therefore a need to study the inflammatory mechanisms of exacerbations and, as biopsy studies are difficult at exacerbation, non-invasive measurements are essential. In this issue of Thorax Biernacki and colleagues describe the measurement of the inflammatory mediator leukotriene B4 (LTB4) and 8-isoprostane as a marker of oxidative stress, both in exhaled breath condensate. This study is particularly welcome as it has been performed exclusively in primary care and shows that these measurements are feasible in the community. All the exacerbations had the three major criteria of increased dyspnoea, sputum volume and purulence. Oral steroids were not used as the exacerbations were not considered to be sufficiently severe. At exacerbation, rises were seen in the exhaled markers which decreased by 2 weeks and had fallen further by 2 months, emphasising the important point that . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Pulmonary hypertension in patients with COPD: NO treatment?
J Pepke-Zaba and N W Morrell
Thorax 2003 58: 283-284. [Extract] [Full Text] [PDF]

Second line treatment for severe acute childhood asthma
M South
Thorax 2003 58: 284-285. [Extract] [Full Text] [PDF]

Controlled prospective randomised trial on the effects on pulmonary haemodynamics of the ambulatory long term use of nitric oxide and oxygen in patients with severe COPD
K Vonbank, R Ziesche, T W Higenbottam, L Stiebellehner, V Petkov, P Schenk, P Germann, and L H Block
Thorax 2003 58: 289-293. [Abstract] [Full Text] [PDF]

Increased leukotriene B4 and 8-isoprostane in exhaled breath condensate of patients with exacerbations of COPD
W A Biernacki, S A Kharitonov, and P J Barnes
Thorax 2003 58: 294-298. [Abstract] [Full Text] [PDF]

Intravenous salbutamol bolus compared with an aminophylline infusion in children with severe asthma: a randomised controlled trial
G Roberts, D Newsom, K Gomez, A Raffles, S Saglani, J Begent, P Lachman, K Sloper, R Buchdahl, and A Habel
Thorax 2003 58: 306-310. [Abstract] [Full Text] [PDF]

T cell cytokine profiles in childhood asthma
V Brown, T J Warke, M D Shields, and M Ennis
Thorax 2003 58: 311-316. [Abstract] [Full Text] [PDF]

Individualised homeopathy as an adjunct in the treatment of childhood asthma: a randomised placebo controlled trial
A White, P Slade, C Hunt, A Hart, and E Ernst
Thorax 2003 58: 317-321. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Griffiths, M. J.D., Evans, T. W. (2005). Inhaled Nitric Oxide Therapy in Adults. NEJM 353: 2683-2695 [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Chest Medicine Jobs

Chest Medicine Jobs